Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.

Addiction biology - 1 Apr 2009

Ebner Nina, Wanner Christian, Winklbaur Bernadette, Matzenauer Christian, Jachmann Crispa Aeschbach, Thau Kenneth, Fischer Gabriele

Abstract excerpt

Hepatitis C viral (HCV) infection is present in 30 to 98% of intravenous drug users. Intravenous substance abuse represents the main route of HCV transmission in industrialized countries. A multi-centre, randomized, controlled, prospective study assessed sustained virological response (SVR), adverse events such as depressive episodes and retention rate of HCV treatment in opioid-dependent patients. Stabilized,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Opioid-Related Disorders

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 19291011
DOI: 10.1111/j.1369-1600.2009.00148.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.PMID 19291011Read ↗

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.Semantic proximity Read ↗

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.Semantic proximity Read ↗

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Semantic proximity Read ↗

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.Semantic proximity Read ↗

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.Semantic proximity Read ↗

Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy.Semantic proximity Read ↗

Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.Semantic proximity Read ↗

[Short-term treatment of Hepatitis C in heroin-dependent patients].Semantic proximity Read ↗

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use.Semantic proximity Read ↗

The success of treatment of chronic hepatitis C in opiate addicts in Clinical Center of Vojvodina.Semantic proximity Read ↗

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.Semantic proximity Read ↗

PS2-10: Predictors of Depression and Poor Physical Health among Patients with Chronic Hepatitis C Infection: Results from the Chronic Hepatitis Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.